Endocrine therapy is a cornerstone of treatment for hormone receptor-positive breast cancer in premenopausal women. However, the optimal treatment approach remains complex and nuanced. Aromatase inhibitors (AIs) are highly effective in postmenopausal women, but their use in premenopausal women...
